Dr. Reddy's Labs Unveils Renvela Generic Sevelamer Carbonate In U.S

An image of a pen pointing at a stock chart Credit: Shutterstock photo

(RTTNews.com) - Dr. Reddy's Laboratories Ltd. (RDY, DRREDDY) announced Thursday the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets.

It is a therapeutic equivalent generic version of Renvela (sevelamer carbonate) for Oral Suspension, approved by the U.S. Food and Drug Administration.

Renvela is a trademark of French drug giant Sanofi (SNYNF, SNY).

Dr. Eddy's noted that the Renvela brand and generic had U.S. sales of approximately $101 million MAT for the most recent twelve months ending in October 2018, according to IMS Health.

Dr. Reddy's Sevelamer Carbonate for Oral Suspension is available in 0.8 g and 2.4 g packets in count size of 90.

Read the original article on RTTNews (http://www.rttnews.com/2965465/dr-reddy-s-labs-unveils-renvela-generic-sevelamer-carbonate-in-u-s.aspx)

For comments and feedback: contact editorial@rttnews.com


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.